(Q37315679)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979516%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

review article

1 reference

title

Tumor cell recognition by the NK cell activating receptor NKG2D (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979516%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979516%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Hans-Gustaf Ljunggren

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979516%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

language of work or name

English

0 references

publication date

1 November 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979516%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

25 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979516%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979516%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979516%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

2957-2961

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979516%20AND%20SRC:MED&resulttype=core&format=json

Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

Promiscuity and the single receptor: NKG2D.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

Evolutionary struggles between NK cells and viruses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

Immune evasion of natural killer cells by viruses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

NKG2D and cytotoxic effector function in tumor immune surveillance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

NKG2D function protects the host from tumor initiation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

Pathobiology of autochthonous prostate cancer in a pre‐clinical transgenic mouse model

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

Cancer immunosurveillance: NKG2D breaks cover

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

Regulation of cutaneous malignancy by gammadelta T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

An activating immunoreceptor complex formed by NKG2D and DAP10

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

The role of the NKG2D immunoreceptor in immune cell activation and natural killing

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

Line of attack: NK cell specificity and integration of signals

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

Activation, coactivation, and costimulation of resting human natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

NKG2D ligands: key targets of the immune response.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

Regulation of ligands for the activating receptor NKG2D.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

Interferons, immunity and cancer immunoediting

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

Therapy-induced antibodies to MHC class I chain-related protein A antagonize immune suppression and stimulate antitumor cytotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

Prospects for the use of NK cells in immunotherapy of human cancer.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

NKG2D blockade prevents autoimmune diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021

Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838833

7 January 2021